These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
927 related items for PubMed ID: 14521506
1. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats. Chamorro V, Wangensteen R, Sainz J, Duarte J, O'Valle F, Osuna A, Vargas F. Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506 [Abstract] [Full Text] [Related]
2. Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan. Yu G, Liang X, Xie X, Yang T, Sun M, Zhao S. Chin Med J (Engl); 2002 Sep; 115(9):1287-91. PubMed ID: 12411096 [Abstract] [Full Text] [Related]
3. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection. Peng F, Lin J, Lin L, Tang H. Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712 [Abstract] [Full Text] [Related]
4. Renal AT1 receptor: computerized quantification in spontaneously hypertensive rats and DOCA-salt rats. Asano N, Ogura T, Mimura Y, Otsuka F, Kishida M, Hashimoto M, Yamauchi T, Makino H. Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):171-80. PubMed ID: 9667071 [Abstract] [Full Text] [Related]
5. Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats. Alvarez Y, Pérez-Girón JV, Hernanz R, Briones AM, García-Redondo A, Beltrán A, Alonso MJ, Salaices M. J Pharmacol Exp Ther; 2007 Apr; 321(1):381-8. PubMed ID: 17244722 [Abstract] [Full Text] [Related]
6. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy. Schiffrin EL, Larivière R, Li JS, Sventek P, Touyz RM. J Cardiovasc Pharmacol; 1995 Apr; 26 Suppl 3():S5-8. PubMed ID: 8587458 [Abstract] [Full Text] [Related]
9. Effects of angiotensin II type-1 receptor blocker losartan on age-related cardiovascular risk in spontaneously hypertensive rats. Mihailović-Stanojević N, Miloradović Z, Grujić-Milanović J, Ivanov M, Jovović D. Gen Physiol Biophys; 2009 Apr; 28 Spec No():112-8. PubMed ID: 19893088 [Abstract] [Full Text] [Related]
10. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Cosentino F, Savoia C, De Paolis P, Francia P, Russo A, Maffei A, Venturelli V, Schiavoni M, Lembo G, Volpe M. Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358 [Abstract] [Full Text] [Related]
11. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin. Jackson EK, Herzer WA, Mi Z, Vyas SJ, Kost CK. J Pharmacol Exp Ther; 1999 Oct; 291(1):115-23. PubMed ID: 10490894 [Abstract] [Full Text] [Related]
15. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II. Gahnem F, Camargo MJ, von Lutterotti N, Laragh JH, Sealey JE. J Hypertens; 1995 Jan; 13(1):91-6. PubMed ID: 7759857 [Abstract] [Full Text] [Related]
16. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats. Kohzuki M, Yasujima M, Kanazawa M, Yoshida K, Fu LP, Obara K, Saito T, Abe K. J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858 [Abstract] [Full Text] [Related]